Gluten Immunogenic Peptides (GIP) Point-of-Care Urine Test in Coeliac Disease Follow-up before and during the COVID-19 Lockdown in Italy
Carolina Ciacci,1 Mario Gagliardi,1 Monica Siniscalchi,1 Monica Ruotolo,1 Antonella Santonicola,1 Najla Hajji,1 Fabiana Zingone2 1Celiac Center at Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy; 2Gastroenterology Unit, Department of S...
Guardado en:
Autores principales: | Ciacci C, Gagliardi M, Siniscalchi M, Ruotolo M, Santonicola A, Hajji N, Zingone F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c216ffca0044d71bcdbd9a51dee9c7c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
El gluten: Su historia y efectos en la enfermedad celíaca
por: PARADA,ALEJANDRA, et al.
Publicado: (2010) -
Sensibilidad no celíaca al gluten: Una patología más que responde al gluten
por: Navarro,Elizabeth, et al.
Publicado: (2015) -
The Gluten-Free Diet for Celiac Disease and Beyond
por: Bara Aljada, et al.
Publicado: (2021) -
Gluten-free diet among school-age children in Olmsted County, Minnesota
por: Eyad Almallouhi, et al.
Publicado: (2017) -
GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice
por: Nakamura T, et al.
Publicado: (2021)